NUWE Nuwellis Inc: Debt to Book Capitalization Ratio

Official company branding of Nuwellis, Inc. (NUWE)

The debt-to-equity structure chart demonstrates the impact of AI-driven robotization of Aquadex console assembly on financial stability. The current level of 0.00 characterizes this leverage assessment parameter. Nuwellis, Inc. (NUWE) revenues are based on the servicing of ultrafiltration systems in cardiology centers, and the high macro-resilience of medical equipment guarantees stable demand regardless of seasonality.

Nuwellis, Inc. - NUWE Debts to Book Capitalization (period 07/04/2022 - 10/29/2026)
Product sample of Nuwellis Corp

Nuwellis, Inc. is scaling its medical technology production through global outsourcing of hardware modules and logistics. This metric measures the share of total liabilities within the business's balance sheet value structure. It allows for an assessment of financial stability and the company's degree of dependence on external borrowings. Reducing leverage minimizes default risks but may limit growth rates. The current trend in the ratio of debt capital to balance sheet capitalization reflects the balance between debt load and investment efficiency.

Competing companies

Debts to Book Capitalization DXCM (DexCom, Inc.)|penumbrainc.com (PEN) - Debts to Book Value|NOVT - Debt to Book Capitalization Ratio|Debt to Net Assets Ratio HAE (Haemonetics Corp)|INSP: Debts to Book Capitalization|Procept (PRCT) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation|pulsebiosciences.com - Debts to Book Capitalization Ratio|Debts to Book Capitalization INMD|PMI - Debts to Book Value|Surmodics Corp - Debt to Book Value|Debts to Book Capitalization Senseonics SENS|NPCE: Debt to Book Value|Tactile Systems Technology - Debt to Book Capital|SNWV: Debts to Book Capitalization|OM - Debts to Net Assets|ELMD (SmartVest) - Debts to Book Capitalization|Debt to Book Value LENSAR Inc (LNSR)|Debt to Book Value RCEL (AVITA Medical, Inc.)|PROF (profoundmedical.com) - Debt to Net Assets Ratio|Debt to Book Capitalization Ratio Baird Medical BDMD|EDAP - Debt to Book Value|Bovie Medical - Debts to Book Capitalization|Debts to Book Value IceCure Medical Ltd|LUNG: Debts to Book Capitalization|Debt to Book Value Ratio TELA|CTSO (CytoSorbents Corp) - Debts to Book Capitalization|Sensus Healthcare Inc (SRTS) - Debts to Net Assets|Debts to Book Capitalization ZYXI|Debt to Book Value electrocore.com ECOR|Debts to Book Capitalization RBOT (Vicarious Surgical)|Debts to Book Capitalization Inspira Technologies Oxy B.H.N. Ltd. IINN|ICU - Debt to Book Capitalization Ratio|IRIX: Debt to Book Capitalization Ratio|INBS (ibs.inc) - Debt to Book Value|Beyond Air - Debt to Net Assets Ratio|PFSA (Profusa Inc) - Debts to Book Capitalization|Debts to Book Value STRATA Skin SSKN|Debt to Book Capitalization Ratio GlucoTrack (GCTK)|NanoVibronix Inc. (NAOV) - Debt to Net Assets|Venus Concept Corp - Debt to Book Value|Debts to Book Capitalization Aethlon Medical Corp AEMD|TransEnterix - Debts to Book Capitalization|Debts to Net Assets avinger.com AVGR|Biosig Technologies (BSGM) - Debt to Book Capitalization Ratio|Debts to Book Capitalization Ratio CUTR (Cutera Inc.)|Debt to Book Capitalization Ratio Know Labs Corp|Debt to Book Value Inari Medical Corp (NARI)|Debts to Book Capitalization NVRO|RSLS - Debts to Book Value|Debt to Book Capitalization Ratio Silk Road Medical SILK